Chronic pelvic pain (CPP) is common in women of reproductive age and has a significant impact on quality of life, work efficiency and healthcare utilization. CPP can be a manifestation of many different, often multifactorial conditions, and in the absence of an identified cause, the management can be particularly challenging. High quality epidemiological studies would improve the understanding of CPP and identify risk factors which may be targeted for the development of appropriate management strategies. This review focuses on what is known about the prevalence, risk factors, individual and societal burden of CPP and outlines important management strategies.
Bibliographical noteFinancial & competing interests disclosure
AA Ayorinde holds a funded PhD studentship at the University
of Aberdeen. GJ Macfarlane is a member of Pfizer’s Inflammation
Competitive Research Programme (I-CRP) grant awarding
panel for which he receives an honorarium. The authors have
no other relevant affiliations or financial involvement with any
organization or entity with a financial interest in or financial
conflict with the subject matter or materials discussed in the
manuscript apart from those disclosed.
No writing assistance was utilized in the production of this
- Chronic pelvic pain
- Risk factors